Adverse events96

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 96

Type	Event	Organ system	Group	Affected	At risk
other	Urinary tract infection	Infections and infestations	Valbenazine 40 mg Through Week 4	0	163
other	Urinary tract infection	Infections and infestations	Valbenazine 40mg Week 4 Through Week 52	3	35
other	Urinary tract infection	Infections and infestations	Valbenazine 80mg Week 4 Through Week 52	9	107
other	Urinary tract infection	Infections and infestations	Valbenazine 80/40mg Week 4 Through Week 52	1	11
other	Headache	Nervous system disorders	Valbenazine 40 mg Through Week 4	0	163
other	Headache	Nervous system disorders	Valbenazine 40mg Week 4 Through Week 52	2	35
other	Headache	Nervous system disorders	Valbenazine 80mg Week 4 Through Week 52	6	107
other	Headache	Nervous system disorders	Valbenazine 80/40mg Week 4 Through Week 52	0	11
serious	Abdominal pain	Gastrointestinal disorders	Valbenazine 40 mg Through Week 4	0	163
serious	Abdominal pain	Gastrointestinal disorders	Valbenazine 40mg Week 4 Through Week 52	0	35
serious	Abdominal pain	Gastrointestinal disorders	Valbenazine 80mg Week 4 Through Week 52	1	107
serious	Abdominal pain	Gastrointestinal disorders	Valbenazine 80/40mg Week 4 Through Week 52	0	11
serious	Non-cardiac chest pain	General disorders	Valbenazine 40 mg Through Week 4	0	163
serious	Non-cardiac chest pain	General disorders	Valbenazine 40mg Week 4 Through Week 52	0	35
serious	Non-cardiac chest pain	General disorders	Valbenazine 80mg Week 4 Through Week 52	1	107
serious	Non-cardiac chest pain	General disorders	Valbenazine 80/40mg Week 4 Through Week 52	0	11
serious	Cholelithiasis	Hepatobiliary disorders	Valbenazine 40 mg Through Week 4	0	163
serious	Cholelithiasis	Hepatobiliary disorders	Valbenazine 40mg Week 4 Through Week 52	0	35
serious	Cholelithiasis	Hepatobiliary disorders	Valbenazine 80mg Week 4 Through Week 52	1	107
serious	Cholelithiasis	Hepatobiliary disorders	Valbenazine 80/40mg Week 4 Through Week 52	0	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02405091/events

API reference For AI assistants

Adverse events96

Sources 3

Read this list from software.